For the quarter ended December 2025, Humana (HUM) reported revenue of $32.64 billion, up 11.8% over the same period last year. EPS came in at -$3.96, compared to -$2.16 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $31.88 billion, representing a surprise of +2.38%. The company delivered an EPS surprise of +1.31%, with the consensus EPS estimate being -$4.01.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Humana performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Benefit ratio - Consolidated: 93% versus 93.3% estimated by eight analysts on average.
- Medical Membership - Medicare stand-alone PDP: 2.46 million compared to the 2.49 million average estimate based on five analysts.
- Medical Membership - State-based contracts and other: 1.62 million versus 1.65 million estimated by five analysts on average.
- Medical Membership - Group Medicare Advantage: 568.4 thousand compared to the 556.51 thousand average estimate based on five analysts.
- Revenues- Consolidated- Investment income: $132 million compared to the $272.61 million average estimate based on nine analysts. The reported number represents a change of -55.6% year over year.
- Revenues- Consolidated- Total premiums: $30.88 billion versus the nine-analyst average estimate of $30.23 billion. The reported number represents a year-over-year change of +11.3%.
- Revenues- Consolidated- Total services revenue: $1.5 billion versus $1.42 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +28.6% change.
- Insurance- Services revenue- Military services and other: $292 million versus $255.83 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +19.2% change.
- CenterWell- Total revenues: $5.96 billion compared to the $5.53 billion average estimate based on six analysts. The reported number represents a change of +16.2% year over year.
- Insurance- Total revenues: $31.34 billion versus $30.62 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +11.3% change.
- CenterWell- Total services revenue: $1.21 billion versus the six-analyst average estimate of $1.2 billion. The reported number represents a year-over-year change of +31.9%.
- CenterWell- Services revenue- Pharmacy solutions: $267 million versus $303.12 million estimated by five analysts on average.
View all Key Company Metrics for Humana here>>>
Shares of Humana have returned -33.8% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Humana Inc. (HUM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
